Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis

Erythropoiesis-Stimulating Agents in Oncology

(2017) John A. Glaspy   Journal of the National Comprehensive Cancer Network

Erythropoietin Promotes the Growth of Tumors Lacking Its Receptor and Decreases Survival of Tumor-Bearing Mice by Enhancing Angiogenesis

(2015) Tatsuma Okazaki et al.   NEOPLASIA

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

(2010) J Glaspy et al.   BRITISH JOURNAL OF CANCER

Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression

(2010) Ilan Shimon et al.   Pituitary

Erythropoietin and Tumor Angiogenesis

(2009) Domenico Ribatti   STEM CELLS AND DEVELOPMENT

The erythropoietin receptor in normal and cancer tissues

(2008) Wolfgang Jelkmann et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

(2008) Robert E. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

(2007) Gillian Thomas et al.   GYNECOLOGIC ONCOLOGY